Ingredion Incorporated
WESTCHESTER, Ill., March 16, 2021 (GLOBE NEWSWIRE) -- Today, the board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.64 per share on the Company’s common stock. The dividend is payable on April 26, 2021, to stockholders of record at the close of business on April 1, 2021.
About the Company
Ingredion Incorporated (NYSE: INGR) headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2020 annual net sales of $6 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion Idea Labs® innovation centers around the world and approximately 12,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.
CONTACT:
Investors: Tiffany Willis, 708-551-2592
Media: Becca Hary, 708-551-2602
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Kapitalforeningen IA Invest24.10.2025 09:01:16 CEST | Pressemeddelelse
Kapitalforeningen IA Invest – Prospekt
Afarak Group SE24.10.2025 09:00:00 CEST | Press release
AFARAK GROUP INVESTS IN PRODUCTION OF METALLURGICAL GRADE CHROME ORE CONCENTRATE
Investeringsforeningen BankInvest24.10.2025 09:00:00 CEST | Pressemeddelelse
Anmodning om suspension for andelsklasser under Investeringsforeningen BankInvest
Karolinska Development AB (publ)24.10.2025 08:45:00 CEST | Press release
Karolinska Development’s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D
Danske Invest Select24.10.2025 08:30:57 CEST | Pressemeddelelse
Ændring af emissionstillæg for Investeringsforeningen Danske Invest Select
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
